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     BACKGROUND 
 With the launch of the Roll Back Malaria (RBM) Partnership 
in 1998, global malaria control partners set out to “halve the 
burden of malaria by 2010,” by reducing malaria-associated 
morbidity and mortality by that amount.  1   In Abuja, Nigeria, 
the partners committed to achieving 60% coverage with pre-
ventive interventions among those at risk of malaria and 60% 
coverage with prompt and effective treatment among those 
suffering from malaria.  2   With the development of the 2005–
2015 RBM Strategic Plan, the targets were raised to 80% and 
further specified for the interval to 2010 and to 2015, including 
achieving the Millennium Development Goals (MDGs) and 
equitable coverage.  3  
 In November 2007, malaria partners reset ambitious goals to 
include elimination of malaria in some countries as defined in 
the Global Malaria Action Plan of 2008.  4   Although the targets 
for malaria control have changed rapidly in the past decade, 
at the technical level of monitoring and evaluation, the mea-
sures have adhered to the standard monitoring and evaluation 
(M&E) framework.  5  
  Here, the national malaria control program effort in Zambia 
is reviewed as an example of a fully malaria-endemic country 
that achieved rapid success from 2005 through 2008 and is mov-
ing to sustain that success and consider next steps to advance 
its control of the malaria burden and transmission. The prog-
ress and components of success to date are described, as are the 
evolving requirements for success as the program proceeds. 
  Country  background:  Zambia.     Zambia has a population of 
approximately 12 million people in 9 provinces and 72 districts 
and is fully malaria endemic with regular and moderate to high 
transmission in all districts and with a seasonal pattern of high 
transmission between December and May associated with the 
rains.  6   Zambia’s initial National Malaria Control Strategic 
Plan covered the period from 2000 to 2005; the plan was 
updated for 2006 to 2010, setting ambitious goals to scale up a 
package of malaria interventions: insecticide-treated mosquito 
nets (ITNs), indoor residual spraying (IRS); prevention with 
intermittent preventive treatment in pregnancy (IPTp) and 
ITNs; and case management with diagnosis using microscopy 
and rapid diagnostic tests (RDTs) and prompt effective 
treatment with artemisinin-based combination therapy (ACT) 
using artemether-lumefantrine (AL); see   Table 1  . Detailed 
information on Zambia malaria and malaria control efforts 
during the past decade can be found elsewhere.  7,  8  
         METHODS AND  DATA SOURCES 
  Available information was reviewed from national surveys, 
program data, special studies, and in-country reports to assess 
malaria control progress in Zambia. After the standard monitor-
ing and evaluation framework for RBM,  5  authors examined pol-
icy and strategy decision making, the use of financial resources 
(inputs), service delivery (process and outputs), intervention 
coverage (outcomes), and health and economic improvements 
(impact) across urban and rural settings and across socioeco-
nomic strata. Data available from the standard published reports, 
surveys, and special studies were reviewed and compared over 
time; no additional within-survey analyses were undertaken. 
  To ensure that available prevention and treatment inter-
ventions reach all Zambians, the Zambia National Malaria 
Control Center (NMCC) monitored commodity procure-
ment and distribution. To assess progress toward achiev-
ing greater than 80% population coverage targets, several 
household surveys were considered, including the national 
UNICEF Multiple Indicator Cluster Survey (1999 MICS  9 ), 
Demographic and Health Surveys (2001/2  10   and 2007  11 -DHS), 
and Malaria Indicator Surveys (2006  12   and  2008 13 -MIS),  as  well 
as the smaller-scale 2004 Roll Back Malaria (2004-RBM  14 ) 
survey. These national surveys rely on asset-based indices 
to create relative proxy measure of household wealth.  15   The 
NMCC also tracked progress using programmatic output 
information on service delivery for malaria interventions 
(e.g., for routine ITN and IRS delivery and operational cov-
erage) and use of RDTs. Routine health management infor-
mation systems (HMIS) reports from health facilities across 
the nation allowed for retrospective tracking of fever cases, 
malaria diagnosis, hospital admissions, and treatment activi-
ties  7,  13  ; however, because of recent modifications in the HMIS 
and some irregularities of reporting, the national evaluations 
here did not include the details of these data. Because envi-
ronmental factors, particularly changes in rainfall patterns, can 
affect malaria transmission, we reviewed 12-month Weighted 
Anomaly Standardized Precipitation (WASP) data between 
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1980 and 2008 to assess possible affects of rainfall variation on 
malaria parasitemia.  16  
   RESULTS 
    Zambia’s malaria control progress.     Sound  policies  attracting 
partners and growing resources.     With a 2006–2010 national 
strategy for malaria control and consistent leadership from the 
Ministry of Health (MoH) and the NMCC, Zambia attracted 
new or increased funding from a variety of bilateral and 
multilateral sources. This began with the United States Agency 
for International Development (USAID) support during 
2000–2003 and expanded greatly with Global Fund grants 
in Round 1, 4, and 7; support expanded further with funding 
from the World Bank, the Malaria Control and Evaluation 
Partnership in Africa (MACEPA, a program at PATH funded 
by the Bill & Melinda Gates Foundation) in 2005, and with 
the U.S. Presidents Malaria Initiative (PMI) in 2007; see 
  Figure 1  . Intermittent support from the Japanese International 
Cooperation Agency (JICA) and district health funding from 
multiple donors contributing to the Sector Wide Approach 
(SWAp) provided a variety of support needed for program 
action. Numerous other partners provided smaller financial 
contributions toward various aspects of technical assistance, 
advocacy, or service delivery at local level, including the World 
Health Organization (WHO) and UNICEF. The Government 
of the Republic of Zambia (GRZ) also has provided increasing 
resources from 2000 through 2008 for malaria control. In 
many respects, this amount is the most difficult to quantify 
specifically for malaria as the GRZ supports national staff 
providing the majority of services and the facilities (hospitals, 
health centers, health posts, laboratories, etc.) where malaria 
control and a range of other services are delivered. 
    Using  funds  and  delivering  services.     Malaria prevention and 
diagnostic services expanded markedly from 2003 through 
2008. During this period, the Zambia Ministry of Health and 
partners procured and distributed approximately 5.9 million 
ITNs (since 2007 all are long-lasting or LLINs), nearly 80% 
of which were distributed under intensified efforts from 2006 
through 2008, with the largest distribution occurring in 2007 
and less in 2008 because most of the acute need was addressed 
in the previous year (  Figure 2  ). District-based rolling mass 
distribution enabled wide coverage, especially to rural and 
previously poorly served areas (  Figure 3  ). National IRS 
activities including mapping and enumerating IRS target areas, 
procurement of insecticide and spray equipment, and training 
of spray teams, expanded from 5 to 36 districts from the period 
2003–2008. With a strong reproductive health program and 
commitments from non-governmental organizations,† Zambia 
  Table  1 
    National Malaria Strategic Plan targets in Zambia  *     
National Malaria Strategic Plan 2006–2011
Target
ITN coverage target > 80% of HH with average of 3 ITN/HH
IRS coverage target > 85% coverage of eligible HH in 
15 target districts
IPTp coverage target > 80% of pregnant women receiving 
≥ 2 doses IPTp
Target for ITN use in 
pregnant women
> 80% of pregnant women sleeping 
under ITN or in a house with IRS
Target for ITN use in 
children < 5 years of age
> 80% of children < 5 sleeping under 
ITN or in a house with IRS
Target for PECM > 80% of sick persons treated with 
effective antimalarial within 
24 hours of onset
    *      RBM = Roll Back Malaria; ITN = insecticide-treated mosquito nets; HH = household; 
IRS = indoor residual spraying; IPTp = intermittent preventive treatment during pregnancy; 
PECM = prompt effective case management (defined as treatment with recommended anti-
malarial drug within 24 hours of illness onset).   
  Figure   1.        External funding support for Zambia malaria control: estimates for 2003–2008.       
  †     The Churches Association of Zambia (CHAZ), a principal recipient 
of malaria funding from the GF, plays an important role in coordinat-
ing health care service delivery, including antenatal services, among 
an extensive network of religious or mission-based health care facili-
ties throughout Zambia. Population Sciences International (PSI) and 
their local affiliate, Society for Family Health, in Zambia has external 
donor support and works closely with the Reproductive Health Unit 
in the Zambia MOH to deliver malaria prevention through ITNs to 
pregnant women and their children (  http://www.psi.org/Where_We_
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expanded in 2005–2006 and then maintained LLIN and 
IPTp distribution to antenatal clinics in all nine provinces. 
Similarly, Zambia expanded microscopy training, RDT use, 
availability of ACTs in all health facilities, and extended the 
use of antimalarial treatment through an increasing number 
of community health workers trained in malaria diagnosis and 
treatment; however, the evidence for these actions has been 
more descriptive than quantitative.  17,  18  
     Achieving  high  coverage.     Malaria control success is evident 
from population-based surveys monitoring intervention 
coverage rates at household and individual levels. From initial 
low coverage observed in the 2001/2-DHS, Zambia expanded 
malaria prevention coverage between 2004 and 2008.   Figure 4   
shows sequential national survey data demonstrating the 
increases in prevention coverage including ITN ownership, ITN 
use among children and pregnant women, and IPTp coverage 
in pregnancy. The summary figures from national surveys 
suggest that 68% (95% confidence interval [CI]: 64.2–72.4) of 
households have either one or more ITN or received IRS in the 
past year. This represents a 37% percent increase in household 
availability of effective malaria prevention nationally between 
2006 and 2008 and a 5-fold increase between 2001/2 and 2008. 
The IRS coverage increased nearly 66% among districts 
targeted for spraying between 2006 and 2008, representing a 
substantial expansion of within-district coverage into rural, 
more malarious areas. Annual IRS operational coverage 
(the percentage of structures sprayed among those targeted 
each year) in each district has been consistently high since 
2005—exceeding 85% in each target district. At this level of 
population coverage, one can expect that there is substantial 
community benefit even for those without an ITN or IRS.  19,  20  
    The proportion of febrile children less than 5 years of age 
who sought treatment at a facility or from a health care pro-
vider on the same or next day was similar in the MIS-2006 and 
MIS-2008, 60% and 64%, respectively. However, the rates of 
  Figure   2.        Number of insecticide-treated mosquito nets (ITNs) 
distributed structures sprayed and rapid diagnostic tests distributed 
by  year  in  Zambia  between  2003–2008.       
  Figure   3.        Estimated operational coverage of 3 insecticide-treated mosquito nets (ITNs) per household in overlapping 3-year intervals based on 
ITN distributions by district in Zambia during 2003–2008. This figure appears in color at   www.ajtmh.org  .       483 ZAMBIA MALARIA CONTROL
malaria treatment of febrile children less than 5 years of age 
decreased between the MIS-2006 and the MIS-2008 (52.8% 
[95% CI: 44.4–61.3] and 43.3% [95% CI: 39.0–47.6], respec-
tively, an 18% reduction). This coincided with a slight increase 
in the use of ACTs from 9.6% (95% CI: 5.8–13.5) in 2006 to 
12.7% (95% CI: 9.3–16.2) in 2008 and an expansion in the 
distribution of the reported use of malaria diagnostics (note 
that ~2 million RDTs were distributed to districts in 2008, 
  Figure 2  ). Of note, when considering among children treated 
for malaria, ACT was used for 18.6% of treatments in 2006 and 
for 29% of treatments in 2008. This suggests that an increas-
ing proportion of children with fever were tested for malaria 
leading to treatment of malaria only and not non-malarial 
fevers and that there has been some, but incomplete progress 
in using ACT for first line malaria therapy. Unfortunately, rou-
tine health information data does not include reporting from 
all districts on RDT use for testing febrile children, so full data 
are not available to assess national efforts in increasing use 
of diagnostics. Data on diagnostics use from Lusaka District 
(summarized elsewhere  21  ) and data from several rural dis-
tricts  18   show substantial increases in use at least in some parts 
of the country. A summary of the changes in treatment prac-
tices between the Malaria Indicator Surveys of 2006 and 2008 
is shown in   Table 2  . 
        Reduced  disease  and  improved  survival.     Evidence of health 
impact from malaria control in Zambia is mounting, especially 
  Figure   4.        Malaria prevention intervention coverage progress in Zambia, 2002–2008.       
  Table  2 
    Intervention coverage, parasitemia, and anemia changes between MIS-2006 and MIS-2008  *     
    *     HH = household; CI = confidence interval; ITN = insecticide-treated mosquito nets; IPTp = intermittent preventive treatment in pregnancy; ns = not available.   
    †     Women who reported themselves as currently pregnant.   
    ‡     For preventive treatment during pregnancy, estimates are based on the last birth among women during the previous 5 years. For MIS 2006,   N   = 1,572 and for MIS 2008   N   = 2,391.   
    §     Estimates of children with fever are based on   N   = 363 for MIS 2006 and   N   = 843 for MIS 2008.   
Indicator
MIS-2006 MIS-2008 % Change Coverage of intervention
Among households (HHs):   N =   2,881  N =   4,405
HHs with ≥ 1 ITN 37.8% (95% CI: 33.6–42.0) 62.3% (95% CI: 58.2–66.5) ↑ 65%
HHs with ≥ 2 ITNs 14.4% (95% CI: 11.6–17.2) 30.9% (95% CI: 27.6–34.2) ↑ 115%
HHs with IRS in the last 12 months among IRS-targeted districts 25.8% (95% CI: 17.6–34.0) 42.7% (95% CI: 35.0–50.5) ↑ 66%
HHs with ≥ 1 ITN or IRS in last 12 months 43.2% (95% CI: 38.7–47.8) 68.3% (95% CI: 64.2–72.4) ↑ 58%
Among pregnant women (PW)  †  :   N   = 317   N   = 416
PW slept under ITN last night 24.5% (95% CI: 18.9–30.1) 43.2% (95% CI: 36.6–69.3) ↑ 76%
PW  ‡   took any IPTp 71.6% (95% CI: 68.1–75.1) 80.0% (95% CI: 77.3–82.8) ↑ 12%
PW  ‡   took 2 + doses IPTp 58.8% (95% CI: 55.3–62.1) 66.1% (95% CI: 62.9–69.3) ↑ 12%
Among children under age five:   N   = 2,539   N   = 3,866
Child slept under ITN last night 24.3% (95% CI: 21.2–27.5) 41.1% (95% CI: 37.2–45.0) ↑ 69%
Child with fever  §   received any antimalarial treatment 52.8% (95% CI: 44.4–61.3) 43.3% (95% CI: 39.0–47.6) ↓ 18%
Child with fever  §   received antimalarial treatment on same/next day 31.0% (95% CI: 24.2–39.4) 28.9% (95% CI: 24.6–33.3) ↓ 9%
Child with fever  §   had finger/heel prick (diagnostic used) na 10.9% (95% CI: 7.5–14.3) –
Child with fever received Coartem 9.6% (95% CI: 5.8–13.5) 12.7% (95% CI: 9.3–16.2) ↑ 32%
Health outcomes among children < age 5
Malaria parasite prevalence 21.8% (95% CI: 17.2–26.5) 10.2% (95% CI: 7.7–12.6) ↓ 53%
Urban 6.4% (95% CI: 2.7–10.2) 4.3% (95% CI: 2.2–6.3) ↓ 33%
Rural 26.9% (95% CI: 20.9–32.9) 12.4% (95% CI: 9.2–15.7) ↓ 54%
Mean hemoglobin (g/dL) 9.97 (95% CI: 9.80–10.14) 10.91 (95% CI: 10.81–11.0) ↑ 9%
Severe anemia prevalence (Hb < 8.0 g/dL) 13.8% (95% CI: 11.1–16.6) 4.3% (95% CI: 3.3–5.3) ↓ 69%484 CHIZEMA-KAWESHA AND OTHERS
among young children. Compared with MIS-2006, the MIS-
2008, conducted at the same time of year, showed that malaria 
parasite prevalence in children less than 5 years of age was 
reduced by 53% (from 21.8% in 2006 to 10.2% in 2008) and 
moderate-severe anemia (hemoglobin < 8 gm/dL) in these 
children was reduced by 69% (from 13.8% in 2006 to 4.3% in 
2008) and the reduction was seen in all age groups (  Figure 5  ). 
On the basis of analysis from the MIS-2006, children in house-
holds with prevention in place (ITNs or IRS) had consistently 
lower rates of parasitemia and moderate-to-severe anemia.  22   
    In addition to overall reductions in malaria among chil-
dren less than 5 years of age between the MIS-2006 and MIS-
2008, there was a 67% lower parasite prevalence in the first 
12 months of life and a shift in the peak age of prevalence from 
the third year of life in 2006 to the fourth year of life in 2008 
(  Figure 5  ). This observation of delayed first infection and a 
longer parasite-free period in infancy is consistent with find-
ings from the controlled trials of ITNs  23   and is consistent with 
the observed improved infant survival also seen in those stud-
ies. Similarly, the substantial reduction in moderate-to-severe 
anemia rates occurred in all age groups among the children 
less than 5 years of age and this reduction is consistent with 
further improvements in infant and child survival. 
  National survey data show that all-cause child mortality has 
decreased by 29% from 168/1000 live births in DHS-2001/2 
to 119/1000 live births in DHS-2007 (  Table 2  ). Although there 
was a non-significant decrease in neonatal mortality (~8% 
decline), the substantial improvement is seen in post-neonatal 
infant mortality (from 28 to 365 days of life: 38% reduction) 
and in the 1- to 4-year-old children (36% reduction). Although 
this marked reduction in all-cause infant and child mortality 
may not be attributable only to improved malaria control, a 
review of other health programs suggests little or no change in 
coverage of interventions for other major causes of child mor-
tality from recent nationally representative surveys (  Table 3  ). 
Review of national rainfall data between 1980 and 2008 
showed that dry years included 1992–1993 and 1994–1998, 
however rainfall was generally above the WASP baseline for 
most of the decade from 1999 to 2008 and this was particularly 
true for the interval from 2006 to 2008. Thus, it is unlikely that 
changes in rainfall patterns account for the reduced malaria 
during this recent interval. 
        Interventions  have  reached  rural  and  poor  populations.  
  The high national coverage rates extend to the poorer, more 
rural, and more malarious areas in Zambia. The coverage 
rates for the lowest wealth quintile households are shown in 
  Figure 6   and equity ratios, defined as the wealth index quintile 
ratio between the least-poor households and the poorest 
households, of the key malaria indicators are presented. For 
each prevention and fever treatment indicator, the equity 
index has moved closer to 1.0 in the MIS-2008 compared 
with the MIS-2006; there has been no significant change for 
the IPTp indicators but these measures have an equity index 
close to 1.0 in both years; and for the morbidity indicators 
(where their equity index is less than 1.0—with parasitemia 
and anemia more common in poorer households), the anemia 
equity index has moved closer to 1.0. These findings suggest 
that progress has been made between 2006 and 2008 across 
the coverage indicators toward more equitable availability 
and use of malaria interventions and substantial and equitable 
reductions in malaria parasitemia and anemia. 
      DISCUSSION 
  In the years 2005 through 2008, Zambia systematically 
tracked malaria control program success in terms of attract-
ing and using growing financial resources; increasing pro-
curement and distribution of key commodities to homes and 
health facilities; increasing national coverage of interventions 
(particularly the prevention interventions of ITNs, IRS, and 
IPTp); reducing infection and illness; improving post-neonatal 
infant and child survival; and achieving equity of service deliv-
ery with concomitant disease reduction among the poorest 
and rural populations. 
  The documented progress is remarkable and to be cele-
brated by the country and those who contributed importantly 
in the work. The findings are consistent with what is known 
about the efficacy of the individual interventions.  24–  28   The 
  Figure   5.        Child parasitemia and anemia rates by age group—findings from the Zambia 2006 and 2008 Malaria Indicator Surveys (MIS).    485 ZAMBIA MALARIA CONTROL
documented reduction in all-cause child mortality (29% over-
all and ~37% in the post-neonatal infant and child periods) 
is substantial and perhaps larger than would be anticipated 
on the basis of malaria control alone. Although we looked 
for other disease prevention and control work that might be 
important contributing factors, none were readily apparent. 
Of note, although there was no change in childhood stunt-
ing and wasting, there was a 48% reduction in underweight 
children and this may have been due both to less repeated 
malaria infections and other factors of nutrient intake. There 
was an increase in the proportion of children with exclusive 
breast feeding in the first 6 months of life but this was coupled 
with a reduction in the proportion of children with continued 
breast feeding after 20 months of age. The rapid success seen 
in Zambia may be explained by the country’s broadly semi-
immune population which, when quickly covered with highly 
effective interventions that markedly decrease malaria trans-
mission intensity, will show dramatic improvements within 
one malaria transmission season. 
  The consistency of the findings across the spectrum of 
receiving funding, documenting procurement and distribution 
of malaria prevention commodities, achieving high and equi-
table coverage, and showing national data on reduced mor-
bidity and mortality makes a compelling story that malaria 
control is working. At the local level in communities and 
health facilities, the story is similar. The introduction of sys-
tems to record malaria outpatient cases, inpatient cases, and 
malaria deaths, with the presence of stable diagnostic capacity, 
have documented decreasing slide positivity rates in several 
facilities where reporting has been consistent and where inter-
ventions have been introduced.  21   Similarly, the routine health 
information systems in districts where stable reporting has 
been maintained over time are showing substantial declines 
in both malaria infections and cases in malaria deaths.  29   Thus, 
the national survey data and the local HMIS data are showing 
consistent progress in recent years. 
  Efforts in Zambia from 2005 through 2008 focused on scal-
ing up malaria prevention services (ITNs and IRS for house-
holds, IPTp and ITNs for pregnant women), whereas curative 
services emphasized provision of improved diagnostics and 
quality of care for those attending facilities for malaria epi-
sodes.  30   Despite being an early adopter of artemisinin-based 
combination therapy for treatment of malarial episodes,  31  
access to health care treatment services, especially in rural 
areas, remains challenging because of insufficient human 
resources for health  32   and the difficulties in increasing quality 
care for febrile episodes.  11,  13   The Government of Zambia took 
bold steps to address universal access to health care by remov-
ing user fees in 2006 for rural areas,  33   but many challenges 
remain to adequately address staffing requirements to meet 
established plans. More recently, the National Malaria Control 
Program embarked on an ambitious plan to train community 
health workers in malaria testing and treatment in response to 
calls for expanding access to treatment services.  34,  35  
  The nation of Zambia and its donor partners have invested 
extensively in malaria control and would undoubtedly like to 
see socio-economic progress along with the documented dis-
ease burden reduction. Although not a fully national effort, a 
recent review of data in the copper mining and sugar indus-
tries where company-supported malaria control efforts in 
the workforce and in the surrounding communities showed 
that this investment is improving production and is cost 
  Table  3 
    Information related to major child health program coverage that may have contributed to reductions in all-cause child mortality between the 
DHS-2001/2 and the DHS-2007   
Indicator 2001/2 DHS 2007 DHS Percent change (%)
Mortality rates  * 
Infant mortality (0–11 months) 95 70 ↓ 26
Neonatal mortality (< 1 month) 37 34 ↓ 8
Post-neonatal mortality (1–11 months) 58 36 ↓ 38
Child mortality (1–4 yrs) 81 52 ↓ 36
Under 5 mortality (0–5 years) 168 119 ↓ 29
Coverage of interventions among children
Percent stunted (children under 5 years) 46.8 45.4 ↓ 3
Percent wasted (children under 5 years) 5.0 5.2 ↑ 4
Percent underweight (children under 5 years) 28.1 14.6 ↓ 48
Percent of youngest children under 6 months who are exclusively breastfed 40.1 60.9 ↑ 52
Percent of children age 12–15 months still breastfeeding 96.8 93.8 ↓ 4
Percent of children age 20–23 months still breastfeeding 55.5 41.7 ↓ 25
Percent of children age 12–23 months with BCG vaccination 94.0 92.3 ↓ 2
Percent of children age 12–23 months with at least 3 polio vaccinations 80.2 77.0 ↓ 4
Percent of children age 12–23 months with measles vaccination 84.4 84.9 ↑ 1
Percent of children age 0–59 months with diarrhea in the 2 weeks preceding the 
survey who received oral rehydration salts (ORS) or recommended home fluids 66.9 66.8 ↔ 0
Percent of children age 0–59 months with acute respiratory infection (ARI) in the 
2 weeks preceding the survey who were taken to a health provider 69.1 68.2 ↓ 2
Percentage of households with at least one ITN 13.6 53.3 ↑ 292
Percentage of children 0–59 months who slept under an ITN on the previous night 9.8 28.5 ↑ 192
Percentage of pregnant women 15–49 who slept under an ITN on the previous night 7.9 32.7 ↑ 314
Percent of children age 0–59 months with a fever in the 2 weeks preceding the survey 
who took an anti-malarial drug 51.9 38.4 ↓ 27
Percent of children age 0–59 months with a fever in the 2 weeks preceding the survey 
who took an anti-malarial drug the same day/next day after developing fever 36.8 20.5 ↓ 44
    *     Mortality calculated as deaths per 1,000 live births except for child mortality, which is calculated as deaths per 1,000 children surviving to 12 months of age.   
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saving. Industry-collected data between 2001 and 2007 show 
that their investment in prevention has led to marked reduc-
tion in malaria cases in their workforce and families and 
improved work attendance, production-per-worker, and over-
all production for the plants. The data from 2006 accounting 
for money spent on malaria prevention and treatment and 
money recouped from fewer cases, fewer lost work hours and 
better production showed that Mopani Copper Mines saved 
US$295,718 and Zambia Sugar PLC saved US$550,379—
saving approximately two dollars for every dollar invested 
in malaria prevention.  36   Although it will take some time to 
assess links between malaria control and fully national eco-
nomic benefits, the results of these industry studies are quite 
encouraging. 
  In the context of implementing a national program, there is 
no comparison population, other than historical, so this report 
can only be descriptive. However, information presented is 
from standard documented sources (DHS and MIS surveys, 
administrative and HMIS data, and industry case studies con-
ducted with support from academic institutions) and the sum 
of these provides a broad consistency to the findings. This pre-
liminary assessment of the dramatic drop in child mortality 
rates will be augmented by future national mortality stud-
ies allowing further exploration and analysis over time. The 
mortality data collected is “all-cause mortality” and not dis-
ease specific; thus, the further analysis will have limited abil-
ity to directly explore the contribution of malaria control 
to malaria-specific mortality decline. In addition, the DHS 
measures child mortality in the interval up to 5 years before 
the survey (e.g., 2007 survey measures mortality from 2003 
through 2007), however this likely includes changes that might 
have occurred related to the scale up of malaria control inter-
ventions in the 2005–2007 interval. Although theoretically one 
could examine mortality rates in the 2003–2004 interval and 
compare them with the 2005–2007 interval, the DHS sample 
size precludes statistically relevant comparisons for these sub-
analyses. Recognizing these limitations, the initial review of 
the DHS survey data in 2001/2 and 2007 suggests that the larg-
est change in disease control has been the rapid scale up of 
malaria interventions and this likely has contributed impor-
tantly to the overall improved child survival. 
  Zambia is now moving toward completing the final steps 
for achieving and sustaining high national coverage rates of 
malaria control interventions to further reduce the remaining 
morbidity, mortality, and transmission. Much of the success in 
reducing illness and death has already been achieved and one 
can anticipate that further declines in illness and death rates 
will be only modest in comparison to what has already been 
achieved. Thus, future success will be seen in holding mor-
bidity and mortality at these new low levels and any future 
improvements will need to be compared with the pre-scale-up 
mortality estimates from the DHS 2001/2. As Zambia expands 
program work to further reduce malaria transmission, the pro-
gram will need to consider specific measures of transmission 
  Figure   6.        Changes in intervention coverage and prevalence of malaria and moderate-severe anemia in poorest households and changes in the 
equity ratio* between 2006 and 2008, Zambia.       487 ZAMBIA MALARIA CONTROL
that can be tracked over time to understand success in the 
future. 
   CONCLUSION 
  Zambia, a fully malaria-endemic country, has achieved 
substantial and rapid success in reducing the malaria bur-
den across the nation. The findings here show that the suc-
cess in malaria control can be systematically tracked across 
policy improvements, financial investments, actions of pro-
curement and distribution, increases in intervention coverage, 
reductions in illness and death, with improvements across all 
populations including the poor and rural areas, and achieving 
economic benefits. Sustaining these gains will be extremely 
important, but this next sustaining phase will not be accom-
panied by huge new reductions in illness and death as the 
current much lower levels suggest that the remaining child 
morbidity and mortality may be the result of other causes. This 
could lead to complacency in malaria control efforts within 
the country and from the external partners that have greatly 
aided this effort. Decision makers could move to support new 
and different priorities; if the complacency or shifting focus 
leads to undoing current gains against malaria, high malaria 
morbidity and mortality rates can be expected to return as has 
occurred elsewhere in recent times.  37–  39   Thus, the critical next 
step is to sustain the current gains and further reduce malaria 
transmission. The scale up phase in malaria control was ini-
tially thought to be quite challenging; it may be the easy part 
as countries and partners target sustained malaria control and, 
ultimately, malaria elimination. 
  For Zambia to take additional steps to reduce the remaining 
malaria transmission, continued resources and new work will 
be required. As the infection and disease become more focal, 
community techniques to map malaria cases and transmission 
and an approach of testing and treating the remaining infected 
population will be required.  40   This approach is under consider-
ation in an initial set of villages. Only by anticipating the next 
steps in sustained control, presumably the same steps that will 
be ultimately needed for elimination, will Zambia (and other 
countries) be able to achieve final malaria control success. 
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